| Literature DB >> 28962487 |
Alaa El-Din H Sayed1, Remon M Zaki2, Adel M Kamal El-Dean2, Abdullah Y Abdulrazzaq2.
Abstract
Synthesis of bi functionally substituted thieno[2,3-c]pyrazole compounds was carried out by a new method. The substituted group at position five is namely (Entities:
Keywords: Clarias gariepinus; RBCs; Synthesis; Thienopyrazole; Thienopyrazolopyrimidine
Year: 2015 PMID: 28962487 PMCID: PMC5598507 DOI: 10.1016/j.toxrep.2015.10.008
Source DB: PubMed Journal: Toxicol Rep ISSN: 2214-7500
The fish groups exposed to 4-nonyphenol (0.1 mg/l), chemicals compounds (10 mg/kg body weight) and their combinations.
| Group | 1 | 2 | 3 | 4 | 5 | 6 | 7 |
|---|---|---|---|---|---|---|---|
| Treatment | |||||||
| 4-Nonylphenol | 0 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 |
| 4-Amino-3-methyl-1-phenyl-1 | 0 | 0 | 10 | 0 | 0 | 0 | 0 |
| 4-Amino-3-methyl-1-phenyl-1 | 0 | 0 | 0 | 10 | 0 | 0 | 0 |
| 4-Amino-N-(4-methoxyphenyl)-3-methyl-1-phenyl-1 | 0 | 0 | 0 | 0 | 0 | 10 | 0 |
| 4-Amino-N-(4-chlorophenyl)-3-methyl-1-phenyl-1 | 0 | 0 | 0 | 0 | 10 | 0 | 0 |
| 4-(2-Chloroacetamido)-3-methyl-1-phenyl-1 | 0 | 0 | 0 | 0 | 0 | 0 | 10 |
Altered erythrocytes in the African Catfish Clarias gariepinus exposed to 4-nonylphenol in combination with thieno[2,3-c]pyrazole compounds. The data are presented as means ± S.E. (range). N = 9.
| Parameters | Control | 4-Nonyl phenol | 4-Nonylphenol with amino-carbonitrile | 4-Nonylphenol with amino carboxamide | 4-Nonylphenol with amino- | 4-Nonylphenol with amino- | 4-Nonylphenol with 4-(2-chloroacetamido)-3-methyl-1-phenyl-1 |
|---|---|---|---|---|---|---|---|
| Altered erythrocytes % | 1 ± 0.3 | 40.3 ± 4.87 | 12 ± 1.03 | 0.6 ± 0.16 | 28.3 ± 2.04 | 3.7 ± 0.37 | 29.1 ± 3.05 |
| (03)d | (1262)a | (518)c | (01)d | (1537)b | (25)cd | (1443)b |
The physical properties of compounds (6af) and (7af).
| Compound no. | (6af) and (7af) | ||||||
|---|---|---|---|---|---|---|---|
| Mol. formula | M.P. | Solvent of crystallization | C | H | N | S | |
| 6a | C13H10N4S | 7880 | Ethanol | 61.40 | 3.96 | 22.03 | 12.61 |
| 61.15 | 4.10 | 21.93 | 12.75 | ||||
| 6b | C13H12N4OS | 144146 | Ethanol | 57.34 | 4.44 | 20.57 | 11.77 |
| 57.26 | 4.50 | 20.60 | 11.60 | ||||
| 6c | C19H16N4OS | 128130 | Ethanol | 65.50 | 4.63 | 16.08 | 9.20 |
| 65.72 | 4.55 | 15.95 | 9.40 | ||||
| 6d | C20H18N4OS | 118120 | Ethanol | 66.28 | 5.01 | 15.46 | 8.85 |
| 66.08 | 4.95 | 15.35 | 8.68 | ||||
| 6e | C20H18N4O2S | 148150 | Ethanol | 63.47 | 4.79 | 14.80 | 8.47 |
| 63.55 | 4.70 | 14.77 | 8.32 | ||||
| 6f | C19H15ClN4OS | 132134 | Ethanol | 59.60 | 3.95 | 14.63 | 8.37 |
| 59.80 | 3.90 | 14.70 | 8.50 | ||||
| 7a | C13H10N4S | 198200 | Ethanol +Dioxane | 61.40 | 3.96 | 22.03 | 12.61 |
| 61.30 | 3.90 | 22.16 | 12.52 | ||||
| 7b | C13H12N4OS | 214216 | Ethanol +Dioxane | 57.34 | 4.44 | 20.57 | 11.77 |
| 57.30 | 4.40 | 20.55 | 11.67 | ||||
| 7c | C19H16N4OS | 202204 | Ethanol +Dioxane | 65.50 | 4.63 | 16.08 | 9.20 |
| 65.76 | 4.50 | 16.15 | 9.35 | ||||
| 7d | C20H18N4OS | 200202 | Ethanol +Dioxane | 66.28 | 5.01 | 15.46 | 8.85 |
| 66.10 | 4.90 | 15.50 | 8.75 | ||||
| 7e | C20H18N4O2S | 208210 | Ethanol +Dioxane | 63.47 | 4.79 | 14.80 | 8.47 |
| 63.42 | 4.85 | 14.60 | 8.55 | ||||
| 7f | C19H15ClN4OS | 204206 | Ethanol +Dioxane | 59.60 | 3.95 | 14.63 | 8.37 |
| 59.70 | 4.00 | 14.57 | 8.41 | ||||
Spectral analysis of compounds 6af and 7af.
| Compound No. | IR (KBr, cm1) | 1H NMR, 13C NMR (ppm) | Mass spectra |
|---|---|---|---|
| 6a | ν: 3035 (CH aromatic), 29852925 (CH aliphatic), 2275, 2227 (2CN) cm1 | 1H NMR: (90 MHz, DMSO-d6) δ:2.85 (s, 3H, CH3), 3.85 (s, 2H, CH2), 7.607.40 (m, 5H, ArH) ppm | EI-MS ( |
| 6b | ν: 3450, 3300 (NH2), 3050 (CH aromatic), 2920, 2850 (CH aliphatic), 2210 (CN), 1660 (CO amide), 1590 (C = N) cm1 | 1H NMR: (400 MHz, DMSO-d6) δ: 2.35 (s, 3H, CH3), 3.30 (s, 2H, CH2), 7.15 (s, 2H, NH2 disappeared by D2O), 7.307.70 (m, 5H, ArH) ppm | EI-MS ( |
| 6c | ν: 3160 (NH), 3057 (CH aromatic), 2920.81,2885 (CH aliphatic), 2227 (CN), 1654 (CO) cm1 | 1H NMR: (400 MHz, DMSO-d6) δ: 2.56 (s, 3H, CH3), 4.03 (s, 2H, CH2), 7.087.52 (m, 10H, ArH), 10.15 (s,H,NH) ppm. | |
| 6d | ν: 3130 (NH), 3070 (CH aromatic), 2905, 2885 (CH aliphatic), 2220 (CN), 1660 (CO) cm1 | 1H NMR: (400 MHz, DMSO-d6) δ: 2.31 (s, 3H, CH3 | |
| 6e | ν: 3303 (NH), 3035 (CH aromatic), 2975, 2870 (CH aliphatic), 2229 (CN), 1654 (CO) cm1 | 1H NMR: (400 MHz, DMSO-d6) δ: 2.52 (s, 3H, CH3pyrazole), 3.75 (s,3H, CH3 | |
| 6f | ν: 3303 (NH), 3035 (CH aromatic), 2975, 2870 (CH aliphatic), 2229 (CN), 1654 (CO) cm1 | 1H NMR: (400 MHz, DMSO-d6) δ: 2.32 (s, 3H, CH3), 3.70 (s, 2H, CH2), 7.337.99 (m, 9H, ArH), 10.28 (s,H,NH) ppm. | |
| 7a | ν: 3455, 3359, 3200 (NH2), 3045 (CH aromatic), 2950, 2890 (CH aliphatic), 2184 (CN) cm1 | 1H NMR: (400 MHz, DMSO-d6) δ: 3.37 (s, 3H, CH3), 6.93 (s, 2H, NH2), 7.26-7.56 (m, 5H, ArH) ppm. 13C NMR (100 MHz, DMSO-d6) δ: 13.0 (CH3pyrazole), 71.22, 116.32, 140.79, 143.72, 147.79 (C), 117.16 (CN), 121.57, 125.98, 129.95, 138.31 (Phpyrazole) ppm. | ESI-MS: (C13H10N4S), 254.33 (M+) |
| 7b | ν: 3400, 3305, 3190 (2NH2), 3050 (CH aromatic), 2910(CH aliphatic) cm1, 1635 (CO amide), 1580 (C = N) cm1 | 1H NMR: (90 MHz, DMSO-d6) δ: 2.60 (s, 3H, CH3), 6.90 (s, 2H, NH2 amide), 7.0 (s, 2H, NH2), 7.30-7.70 (m, 5H, ArH) ppm. 13C NMR (100 MHz, DMSO-d6) δ: 15.2 (CH3pyrazole), 109.3, 121.5, 145.4, 145.4, 149.9 (C), 124.4, 128.2, 129.8, 133.1 (Phpyrazole), 169.8 (CONH2). | |
| 7c | ν: 3304, 3200 (NH2), 3135 (NH), 3050 (CH aromatic), 2006, 2887 (CH aliphatic), 1685 (CO) cm1 | 1H NMR: (400 MHz, DMSO-d6) δ: 2.63 (s, 3H, CH3), 6.64 (s, 2H, NH2), 7.108.03 (m, 9H, ArH), 8.89 (s, H, NH) ppm | |
| 7d | ν: 3289, 3215 (NH2), 3130 (NH), 3070 (CH aromatic), 2905, 2885 (CH aliphatic), 1655 (CO) cm1 | 1H NMR: (400 MHz, DMSO-d6) δ: 2.30 (s, 3H, CH3 p-tolyl), 2.63(s,3H,CH3pyrazole) 6.64 (s, 2H, NH2), 7.30-7.58 (m, 9H, ArH), 8.84 (s, H, NH) ppm | |
| 7e | ν: 3429, 3328, 3274.74 (2NH2, NH), 3030 (CH aromatic), 2860(CH aliphatic), 1624 (CO) cm1 | 1H NMR: (400 MHz, DMSO-d6) δ: 2.48 (s, 3H, CH3pyrazole), 3.71 (s, 3H, CH3 | |
| 7f | ν: 3429, 3336, 3275 (2NH2, NH), 3050 (CH aromatic), 2880(CH aliphatic), 1640 (CO) cm1 | 1H NMR: (400 MHz, DMSO-d6) δ: 2.49 (s, 3H, CH3), 7.25 (s, 2H, NH), 7.317.71 (m, 9H, ArH), 9.37 (s, H, NH) ppm. 13C NMR (100 MHz, DMSO-d6) δ: 13.1 (CH3pyrazole), 71.4, 116.3, 147.8, 156.0 (C), 121.0, 129.34, 132.7, 136.0 ( |
Scheme 1Synthesis of 4-amino-3-methyl-5-substituted-1-phenyl-1H-thieno[2,3-c]pyrazoles (7af).
Fig. 1Blood film of control catfish Clarias gariepinus showing the rounded shape of the nucleated erythrocytes (Er) and leucocytes (L). (H&E, ÿ400).
Fig. 2Blood film of catfish Clarias gariepinus treated with 1 mg/l 4-nonylphenol: (a) & (b) showing swelled cells (Sc), sickle cells (Sk) and tear drop like cells (Tr) (H&E, ÿ400).
Fig. 3Blood film of catfish Clarias gariepinus treated with 4-nonylphenol plus4-amino-3-methyl-1-phenyl-1H-thieno[2,3-c]pyrazole-5-carbonitrile: (7a) (a) & (b) showing swelled cells (Sc), sickle cells (Sk), acanthocytecrenated cells (Ac) and cells have prominent vacuoles (Va). (H&E, ÿ400).
Fig. 4Blood film of catfish Clarias gariepinus treated with 4-nonylphenol plus4-amino-3-methyl-1-phenyl-1H-thieno[2,3-c]pyrazole-5-carboxamide (7b) showing normal erythrocytes with presence of few numbers of sickle cells (Sk). (H&E, ÿ400).
Fig. 5Blood film of catfish Clarias gariepinus treated with 4-nonylphenol plus 4-amino-3-methyl-N-phenyl- p-chlorophenyl-1H-thieno[2,3-c]pyrazole-5-carboxamide (VIIf) showing normal erythrocytes with presence of few numbers of sickle cells (Sk). (H&E, ÿ400).
Fig. 6Blood film of catfish Clarias gariepinus treated with 4-nonylphenol plus: 4-amino-3-methyl-1-phenyl-N-p-anisyl-1H-thieno[2,3-c]pyrazole-5-carboxamide (7e) (a) & (b) showing swelled cells (Sc), sickle cells (Sk) and tear drop like cells (Tr). (H&E, ÿ400).
Fig. 7Blood film of catfish Clarias gariepinus treated with 4-nonylphenol plus 4-(2-chloro-acetylamino)-3-methyl-1-phenyl-1H-thieno[2,3-c]pyrazole-5-carboxamide (8): (a) & (b) showing swelled cells (Sc), sickle cells (Sk) and tear drop like cells (Tr). (H&E, ÿ400).